Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lahti

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Dental Research|October 18, 2025
Oral Microbial Determinants of Saliva and Serum Lipopolysaccharide ActivityM Manzoor, J Putaala, S Zaric, et al.
FEBS Letters|March 29, 2011
Engineered epidermal growth factor mutants with faster binding on-rates correlate with enhanced receptor activationJennifer L Lahti, Bertrand H Lui, Stayce E Beck, et al.
Disease Models & Mechanisms|November 5, 2011
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell cultureAnna L Lahti, Ville J Kujala, Hugh Chapman, et al.
International Journal of STD & AIDS|April 6, 2006
Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacyM Lehtinen, I Idänpään-Heikkilä, T Lunnas, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Dental Research|October 18, 2025
Oral Microbial Determinants of Saliva and Serum Lipopolysaccharide ActivityM Manzoor, J Putaala, S Zaric, et al.
FEBS Letters|March 29, 2011
Engineered epidermal growth factor mutants with faster binding on-rates correlate with enhanced receptor activationJennifer L Lahti, Bertrand H Lui, Stayce E Beck, et al.
Disease Models & Mechanisms|November 5, 2011
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell cultureAnna L Lahti, Ville J Kujala, Hugh Chapman, et al.
International Journal of STD & AIDS|April 6, 2006
Population-based enrolment of adolescents in a long-term follow-up trial of human papillomavirus vaccine efficacyM Lehtinen, I Idänpään-Heikkilä, T Lunnas, et al.
Pageof 2